Phenominer Database Results (14 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 17 44.8 % 0.6 2.47 hematocrit analysis 0.0 unx 168 days 99976 2378
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 44.0 % 1.0 3.0 hematocrit analysis 0.0 0 100442 2479
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 41.0 % 1.0 3.0 hematocrit analysis 0.0 0 100436 2479
WKY hematocrit unilateral nephrectomy (for 28 days) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 11 45.2 % 1.4 4.64 hematocrit analysis 0.0 unx 168 days 99975 2378
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 16 45.8 % 0.5 2.0 hematocrit analysis 0.0 unx 168 days 99978 2378
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 16 44.5 % 0.6 2.4 hematocrit analysis 0.0 unx 168 days 99979 2378
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 45.0 % 1.0 2.83 hematocrit analysis 0.0 0 100439 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 44.0 % 1.0 2.83 hematocrit analysis 0.0 PA IV 50mg/kg 490 days 100443 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 7 39.0 % 1.0 2.65 hematocrit analysis 0.0 PA IV 50mg/kg 23 days 100437 2479
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 43.0 % 1.0 2.83 hematocrit analysis 0.0 PA IV 50mg/kg 0 100441 2479
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 17 45.6 % 0.3 1.24 hematocrit analysis 0.0 unx 168 days 99977 2378
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (for 30 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 5 35.0 % 1.0 2.24 hematocrit analysis 0.0 PA IV 50mg/kg 23 days 100438 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 43.0 % 1.0 3.0 hematocrit analysis 0.0 PA IV 50mg/kg 0 100440 2479
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 42.0 % 1.0 3.0 hematocrit analysis 0.0 PA IV 50mg/kg 490 days 100444 2479